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Recently, coronavirus disease (COVID-19) was declared
a pandemic by the World Health Organization (WHO).
The virus that causes the emerging infectious disease was
designated by the International Committee on Taxonomy of
Viruses as severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) (1,2).
COVID-19 has been reported predominantly in adult
patients. The clinical, laboratorial, and radiographic abnorm-
alities for adults with COVID-19 include fever, dry cough,
myalgia, fatigue, chest discomfort, respiratory frequency
430/min, blood oxygen saturation o93%, leukopenia, lym-
phopenia, and chest radiographic or computed tomographic
scan with mild to severe pneumonia (1-3). The most impor-
tant risk factors or comorbidities in adult COVID-19 patients
include: age more than 60 years, cardiovascular disease,
diabetes mellitus, arterial hypertension, chronic respiratory
disease, and cancer (2-4).
In contrast to adults with COVID-19, the majority of
children and adolescents infected with SARS-CoV-2 exhib-
ited milder disease and also presented with nasal congestion,
rhinorrhea, pharyngeal erythema, diarrhea, and vomiting.
These young patients showed an adequate treatment res-
ponse and a short duration to COVID-19 resolution (5,6).
Adolescent populations have rarely been evaluated in the
context of this emerging infectious disease. A recent study
reported on 72,314 patients with COVID-19 from the Chinese
Center for Disease Control and Prevention, 1% of whom
were adolescents (10-19 years) (3). Notably, this infectious
disease occurred in 169/4,212 (4%) adolescents in the
Republic of Korea study (7).
Another Chinese study, including 2,143 pediatric patients,
showed that 35% of the patients were adolescents. Disease
severity was higher in infants than in other pediatric ages.
Severe and critical cases were uncommon in adolescents,
with an occurrence rate of 4% and 3% in the age groups 11-15
and X16 years, respectively (8).
Moreover, silent infection is defined as positivity for
SARS-CoV-2, without any clinical manifestations or chest
imaging abnormalities (9). Adolescent populations frequen-
tly present with asymptomatic SARS-CoV-2 infection, and
these infected populations are the main source of SARS-
CoV-2 infections in the pediatric age group (9,10).
Regarding the pathogenesis of COVID-19, one of the
possible reasons for the lower prevalence of COVID-19 in
children and adolescents than in adults is the lower expres-
sion of the angiotensin-converting enzyme 2 receptor (ACE-2)
in the pediatric age group. This receptor is necessary for the
entry of SARS-CoV-2 into the cells, particularly in the lung,
heart, and intestine (11). ACE-2 expression may increase
angiotensin II production, resulting in an increase in vaso-
constriction and pulmonary vascular permeability (12).
A recent meta-analysis showed that comorbidities may also
be changed by epigenetic regulation, with increased expres-
sion of ACE-2 in human lung cells associated with severe
COVID-19 (13).
As previously mentioned, critically ill cases have been infre-
quently reported in adolescents. Adolescents with severe
acute respiratory failure and multi-organ dysfunction syn-
drome may present signs and symptoms of cytokine storm
syndrome, triggered by SARS-CoV-2. Indeed, this subgroup of
adolescents with COVID-19 may present with high fever;
confusion; anemia; thrombocytopenia; neutropenia; coagulo-
pathy; hyperferritinemia; and elevated liver enzyme, D-dimer,
lactate dehydrogenase, and soluble CD25 levels (14). An
elevated cytokine profile associated with this complication
mainly includes increases in interleukin (IL)-2, IL-7, granulo-
cyte-colony stimulating factor, and tumor necrosis factor-alfa
levels (15). Notably, these findings were similar to the findings
in adolescents with familial hemophagocytic lymphohistiocy-
tosis or macrophage activation syndrome due to systemic
juvenile idiopathic arthritis and in systemic lupus erythema-
tosus patients (16-18).
Furthermore, the prevalence of adolescents with pre-
existing chronic diseases has been rising in the last years,DOI: 10.6061/clinics/2020/e1931
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resulting in considerable morbidity and mortality. These
patients may present high disease complexity and severity
with an unpredictable course, requiring multiple medica-
tions, several physician appointments in outpatient clinics
and emergency departments, several hospital admissions,
and an undoubtedly high risk of infectious diseases. The
most prevalent diagnoses of these chronic conditions in
adolescents are asthma, obesity, cancer, diabetes mellitus,
transplantation, and autoimmune diseases (19-21).
Thus, preexisting chronic conditions in adolescents with
confirmed COVID-19 may be associated with the risk of
progression to severe disease (acute respiratory failure and/
or multi-organ dysfunction syndrome) and death (22). Des-
pite recent publications, the real predisposition and risk
of COVID-19 in adolescent populations with preexisting
chronic conditions are still unknown.
In this regard, this emerging infectious disease appears to
have a milder course and a less aggressive attack rate in the
pediatric population with asthma (23). In contrast, obese
patients may be at a higher risk of impaired outcomes
associated with COVID-19 (24). Chronic hyperglycemia may
impact the immune function and also increases the morbi-
mortality risk due to this acute infectious disease (24). The
long-term effects of this global health emergency, with school
closure, physical inactivity, sedentary behavior, and con-
sumption of calories-dense comfort foods, may increase the
risk of weight gain in teenagers, particularly those living in
urban districts (25-27).
The data of immunocompromised children and adoles-
cents with cancer and COVID-19 are scarce (28-29), as well as
in adult cancer patients (4). The majority of childhood cancers
are aggressive, requiring prompt and intensive multiagent
chemotherapy or stem cell transplantation, and postponing
these treatments are not indicated during this pandemic
(28-29).
In addition, there are limited data regarding COVID-19 in
adolescents and adults with preexisting chronic conditions,
particularly those with autoimmune rheumatic diseases (2,12,
30-32), inflammatory bowel disease (33), autoimmune hepa-
titis, and those undergoing liver transplantation (34). Patients
with these chronic diseases have particular concerns with
regard to their risk of severe infection and to the management
of their immunosuppressive or immune-modifying drug
treatments during the pandemic (35). However, recent data
do not indicate an increased risk of SARS-CoV-2 infection in
patients with these chronic conditions (30-35).
It is notable that the recent Bergamo report showed that
none of the patients who underwent liver transplantation had
severe COVID-19, despite 3/700 (0.4%) having tested positive
for SARS-CoV-2 (34). Another Italian case series showed that
13/320 (4%) adult patients with chronic arthritis under immu-
nosuppressant agents had suspected or confirmed COVID-19.
Only one (0.3%) patient required hospitalization for oxygen
supplementation, and none of them died (36).
Since the pandemic has rapidly deteriorated into a global
crisis, several national and local public health authorities and
international agencies (particularly the WHO) (37), have
regularly provided updated COVID-19 recommendations.
Some additional recommendations are suggested for healthy
adolescents and adolescents with chronic illnesses during
COVID-19:
1. There are six WHO advocacies for parents and adoles-
cents during confinement: 1) one-on-one time (including
talking about sports, cooking, and physical activities), 2)
staying positive in difficult times, 3) creating a daily
routine, 4) avoiding bad behavior and habits, 5) keeping
calm and managing stress, and 6) being honest and
supportive when talking about COVID-19 (37).
2. Adolescents should be encouraged to practice social
distancing to limit potential exposure and to wear masks
to protect against SARS-CoV-2, particularly outside of
the home and during outpatient visits.
3. Telemedicine seems to be an effective and sustainable
technology for adolescents, parents, and multidisciplin-
ary teams. This technology may help conduct online
appointments with respect to adolescent physicians and
pediatric subspecialties during the COVID-19 pandemic
(38-40).
4. Adolescence is a transitional stage involving biological,
psychological, and cultural expressions and cognitive deve-
lopment. During this period, teenagers gradually become
more independent, gaining autonomy from parents, bon-
ding with their peers, and beginning romantic interests
(41,42). Feelings, fear of developing the coronavirus
infection and dying, peer relations, closing of schools and
universities, suspending sporting events, familial finan-
cial loss, domestic conflict, parents’ tension, and novel
daily hygiene habits should be discussed in the adole-
scent appointments. These appointments may be focused
on only teenagers or may include adolescents and their
parents (43,44).
5. A home schooling plan for adolescents should be app-
lied by schools/universities and teachers using online
tools (44).
6. Healthy foods should be reinforced during quarantine,
avoiding ultra-processed foods, reinforcing cooking, and
stocking homemade foods.
7. Physical exercise is essential during the lockdown. There
are several specialized online channels with recreational
activities and easy access via the internet for adolescents
who stay at home. Outdoor activities should be avoided.
8. Quarantine has been a necessary preventive measure
during this pandemic around the world and may result
in negative psychological outcomes in adolescents and
their families. Therefore, information and communica-
tion for adolescents (using telemedicine or telephone
support lines) and motivation through social networking
by mobile phone should be priorities (45). Psychological
and psychiatric issues (such as acute stress, anxiety, dep-
ression, post-traumatic stress disorder, and emotional
exhaustion) may occur or worsen in healthy adolescents
and adolescents with chronic illnesses during the COVID-
19 quarantine/lockdown and social isolation, requiring
online mental health services (as cognitive behavioral
therapy) (39,40,45).
9. Home confinements may induce longer screen time and
sleep issues. Regular sleep patterns and parental control
of screen time should be reinforced during the lockdown.
10. Drinking alcohol does not protect against COVID-19 and
alcohol intake can increase the risk of health issues in
adolescents (37).
11. Since prisons are the epicenters for infectious diseases,
the prevention and control of COVID-19 are required
for specific adolescents and youth populations in jail,
including individual protection measures, social distan-
cing, regular environmental cleaning, and limiting prison
visits (46,47).
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12. During the pandemic, routine appointments and elec-
tive surgeries and procedures should be postponed for
adolescents.
13. The number of subjects visiting adolescents with chronic
diseases must be reduced in outpatient clinics, day-
clinics, and hospitals during the pandemic, especially for
those taking immunosuppressive agents or for pediatric
transplantation patients (29).
14. Adherence to medications should be reinforced for all
adolescents with preexisting chronic disease (42).
15. Immunosuppressive and immune-modifying drug treat-
ments, multiagent chemotherapy, and stem cell trans-
plantation should be evaluated for each adolescent
without COVID-19, according to their specific preexist-
ing chronic disease.
16. Medications should be adjusted or stopped for each
adolescent who has been infected with for SARS-CoV-2
or has been confirmed as having COVID-19 for each
specific preexisting chronic condition. The immunosup-
pressive agents may be restarted after two weeks if the
adolescent has not developed COVID-19 manifestations
or after complete sign and symptom resolution, as
suggested for inflammatory bowel disease patients (35).
17. The comorbidities in adolescents that are associated with
a high risk of severe COVID-19 in adult populations
should be identified, stopped, and/or treated: smoking,
arterial hypertension, diabetes mellitus, asthma, and
chronic kidney disease (2-4).
18. The vaccination card must be updated. During the COVID-
19 pandemic, adolescents with preexisting chronic diseases
should receive the annual influenza vaccine, regardless of
current disease activity and the use of any immunosup-
pressive drug, as suggested for adolescents with auto-
immune rheumatic diseases (48). The adolescents in prison
should also receive this annual immunization.
19. Adolescents with autoimmune diseases, who have
confirmed COVID-19 must be strictly monitored for the
possible risk of reactivation of the disease after the
resolution of this viral infection (32).
20. Owing to the negative economic impact of this pan-
demic, vulnerable adolescents and their families should
receive financial support.
In conclusion, spotlight and recommendations for healthy
adolescents and adolescents with preexisting chronic dis-
eases during the COVID-19 pandemic should be reinforced
for all subjects, particularly for those under quarantine/
lockdown. Further studies will be necessary to clarify and to
assess specific adolescent populations during this emerging
infectious disease pandemic.
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